Theravance Biopharma, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Weiss Asset Management LP and its affiliates have increased their beneficial ownership in Theravance Biopharma, Inc. to 14.5% of outstanding shares.